This compound is a pharmaceutical intermediate containing a boronate ester group, designed for use in boronate synthesis. It features a piperidine-substituted pyridine ring structure with moderate lipophilicity and low polarity, characteristic of research intermediates used in medicinal chemistry.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 852228-08-1
1-Methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine
Research compound
4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]morpholine
Boronic ester research compound
1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Pharmaceutical intermediate for boronate synthesis
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
Pharmaceutical intermediate for boronate synthesis
8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dioxaspiro[4.5]decane
Pharmaceutical intermediate for boronate synthesis
2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 4-methylbenzenesulfonate
pharmaceutical intermediate
2-(4-Fluorophenyl)-5-methylpyridine
pharmaceutical intermediate
1-Boc-3-hydroxypiperidine
Pharmaceutical intermediate for synthesis
2-piperidin-1-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MLJZIQHWAUYAPA-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCCCC3
—